Jeil Pharmaceutical Co.,Ltd (271980.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 222.78B |
| Enterprise Value | 267.32B |
| P/E Ratio | 5.18 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0.28 |
| Price/Book Ratio | 0.7 |
| Enterprise/Revenue | 0.36 |
| Enterprise/EBITDA | 2.28 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.04 |
| Operating Margin | 0.03 |
| Return On Assets | 0.04 |
| Return On Equity | 0.1 |
| Revenue | 566.34B |
| Revenue/Share | 36,559.76 |
| Gross Profit | 208.38B |
| EBITDA | 32.65B |
| Net Income | 23.38B |
| Diluted EPS | 1,604.77 |
| Total Cash | 66.96B |
| Total Cash/Share | 4,579.83 |
| Total Debt | 97.38B |
| Total Debt/Equity | 0.46 |
| Current Ratio | 1.35 |
| Book Value Per Share | 17,609.04 |
| 52-Week Change | -34.13 |
| 52-Week High | 19,290 |
| 52-Week Low | 9,500 |
| Moving Average 50 Days | 12,651.6 |
| Moving Average 200 Days | 14,216.65 |
| Average Volume | 39,183 |
| Shares Outstanding | 14.7M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:5 |
| Last Split Date | April 11, 2018 |